MiNK Therapeutics Inc

NASDAQ:INKT   4:00:00 PM EDT
28.01
-12.60 (-31.03%)
5:30:17 PM EDT: $27.52 -0.49 (-1.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

MiNK Therapeutics Inc Stock, NASDAQ:INKT

149 5th Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8250
Number of Employees: 23
http://www.minktherapeutics.com

Description

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.